Federica Mazzuca | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study		2019
Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours		2019
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient	CASE REPORTS IN ONCOLOGICAL MEDICINE	2019
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival	MEDICAL ONCOLOGY	2018
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?	JOURNAL OF TRANSLATIONAL MEDICINE	2018
Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines	ONCOTARGET	2018
Effect of nutritional support with highly purified, whey proteins for malnutrition and sarcopenia in patients affected with stage II-III colorectal or breast cancer: A blind, placebo controlled, randomized clinical trial	JOURNAL OF CLINICAL ONCOLOGY	2018
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis	PANCREAS	2018
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine	EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY	2017
Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment	ONCOTARGET	2017
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes	ANTICANCER RESEARCH	2017
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient	ANTI-CANCER DRUGS	2017
PD-L1 expression in TNBC: a predictive biomarker of response to neoadjuvant chemotherapy?	BIOMED RESEARCH INTERNATIONAL	2017
The role of stereotactic body radiation therapy in oligometastatic colorectal cancer	MEDICINE	2017
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?	ONCOTARGET	2017
Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong	JOURNAL OF THORACIC DISEASE	2017
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients	JOURNAL OF CLINICAL ONCOLOGY	2017
D23Treatment and outcome for small bowel adenocarcinoma (SBA): a real life experience of two Italian centres	ANNALS OF ONCOLOGY	2017
Being positive despite illness: the contribution of positivity to the quality of life of cancer patients	PSYCHOLOGY & HEALTH	2016
Pre-treatment evaluation of 5-fluorouracil degradation rate. association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort	ONCOTARGET	2016